Agape ATP Corporation — Q1 2024 Form 10-Q
Reporting period: Three months ended March 31, 2024; unaudited U.S. GAAP condensed consolidated statements. The company sells health and wellness products and services, primarily in Malaysia, through network marketing and complementary health therapy operations.
Financial performance and liquidity
| Metric | Q1 2024 | Q1 2023 / comparison |
|---|---|---|
| Revenue | $318,643 | $380,767; down 16.3% |
| Gross profit / margin | $203,420 / 63.8% | $252,408 / 66.3% |
| Operating expenses | $926,958 | $706,293; up 31.2% |
| Operating loss | $723,538 | $453,885 |
| Net loss | $703,094 | $434,075 |
| Net loss attributable to Agape ATP | $709,707 | $425,840 |
| Basic and diluted loss per share | $0.01 | $0.01 |
| Operating cash flow | $(1,243,460) | $(272,555) |
| Cash and cash equivalents | $3,580,526 | $4,832,460 at December 31, 2023 |
| Working capital | $3,428,530 | $4,113,614 at December 31, 2023 |
| Total liabilities | $1,091,180 | $1,363,631 at December 31, 2023 |
Cash includes $244,045 of cash and bank balances and $3,336,481 of time deposits. The company reported no credit facilities and no investing cash flows in Q1 2024. Lease liabilities were $391,? The balance sheet reports operating lease liabilities of $315,525 and finance lease liabilities of $76,551, or $392,076 combined. The filing also lists $28,674 of commitments for short-term operating leases.
Material changes and management commentary
- Network marketing revenue fell 73.3% to $37,079, which management attributed to a limited product range. The company says it is developing a new range of products.
- Complementary health therapy revenue rose 16.4% to $281,564, representing 88.4% of revenue, versus 63.5% in the prior-year quarter.
- General and administrative expense increased 45.5% to $867,266, primarily due to executive and independent director compensation, professional fees and Nasdaq annual listing fees. Selling expense fell 33.8% and commissions declined with network marketing revenue.
- Operating cash use increased substantially. Management attributed the 2024 outflow in part to a $354,839 increase in prepayments and deposits and reductions in payables and accrued liabilities.
- Management is diversifying into renewable energy. It acquired the remaining 50% of OIE ATPC Holdings in March 2024, making it wholly owned; it also decided not to continue developing the subsidiary OIE ATPC Exim. The filing reports no impact on operations from that decision.
Risks, contingencies and unusual items
- Control weakness: Management concluded disclosure controls and internal control over financial reporting were not effective at March 31, 2024. Identified material weaknesses include insufficient accounting personnel with appropriate U.S. GAAP experience and no functional internal audit department. Remediation plans include written procedures, an internal audit function and staff training; management anticipated at least partial implementation by year-end 2024.
- Cash concentration: $3,371,627 of cash and deposits was uninsured at March 31, 2024. The company says it monitors financial institution creditworthiness.
- Supplier concentration: Three vendors represented 64.2%, 18.2% and 12.6% of Q1 purchases. Two vendors represented 73.0% and 24.2% of accounts payable; one is a related party.
- Related-party activity: Q1 purchases from related parties totaled $97,026 for products used in complementary health therapies and beauty products; the filing also reports related-party service and expense transactions.
- Other items: The balance sheet includes a $75,000 tax penalty within accrued liabilities. The company reported no material pending legal proceedings, no significant off-balance-sheet arrangements and no material subsequent events. It recognized $2,217 of forfeited coupon income in Q1 2024, versus $22,959 in Q1 2023.
- Foreign exchange: Revenue and much of the business are denominated in Malaysian ringgit; the company does not hedge currency exposures. Management says direct exposure is currently not significant, but exchange movements may affect U.S.-dollar results and stock value.
No quantified revenue, profit or cash-flow guidance is provided. Management cautions that interim results are not necessarily indicative of full-year or future results.
Investor verification priorities
- Assess whether the planned network marketing product launches can reverse the steep decline in that channel and improve revenue mix.
- Monitor cash burn and the large increase in prepayments and deposits, including their purpose, recoverability and expected conversion to inventory or services.
- Track remediation of the disclosed material weaknesses and whether additional qualified accounting and internal audit resources are put in place.
- Review the economics, funding needs and execution progress of the renewable energy expansion.
- Evaluate exposure to uninsured bank deposits, concentrated vendors, related-party transactions, lease commitments and the recorded tax penalty.